N Colorectal Cancer Screeninghave been performed of the more than 14 million colonoscopies in 2002 in the United States were approximately 40 % for the screening for more than 20 % were or for the follow-up of patients with previous suspicious polyps cancer. Although colonoscopy is a powerful tool for the screening, diagnosis and management, there is a limited resource, according to Dr. Imperiale editorial. If colonoscopy is not properly allocated, some patients may receive no colorectal cancer screening in general.
Quote from the article: . Preliminary clinical trials have indicated negligible toxicity, and Phase II trials a survival benefit a survival benefit after treatment with PROSTVAC , particularly in patients with indolent disease characteristics . Continue reading “Although colonoscopy is a powerful tool for the screening.”